| Title | Institution | Description | Status | Found At |
|---|---|---|---|---|
| Impact of methodological approaches to analysis of AB PET measures | Banner Alzheimer's Institute | Comparing statistical approaches and their effect on interpretive AB PET measures | In Progress | In Progress |
| Trial Baseline Characteristics for API ADAD Colombia Trial | Groupa de Neurosciences, Universidad de Antioquia & Banner Alzheimer's Institute | A description of the characteristics of this cohort including neurocognitive trends at baseline. | In Progress | In Progress |
| Age-related changes in clinical and cognitive measures measured in E2801-psen1 carriers and baseline AB PET measures | Groupa de Neurosciences, Universidad de Antioquia & Familial Dementia Neuroimaging Labratory, Massachusetts General Hospital | Age-related changes in clinical and cognitive measures in E280A-psen1 mutation carriers and non-carriers as well as changes associated with years of education and assessmentment of clinical correlates of baseline AB PET measures. | In Progress | In Progress |
| Detailed analysis of API composite (APCC) by age and mutation status | Alzheimer's Prevention Initiative, Banner Alzheimer's Institute | Detailed analysis of API composite (APCC) by age and mutation status in comparison with the API registry data | In Progress | In Progress |
| Effect of APOE4 carriage on biomarkers | Groupa de Neurosciences, Universidad de Antioquia | To detect and define the effect of APOE4 carriage on biomarkers as seen in the baseline cohort of the API ADAD Colombia trial | In Progress | In Progress |
| Sex difference in cognition and imaging for the API ADAD Colombia trial | Groupa de Neurosciences, Universidad de Antioquia & Banner Alzheimer's Institute | Analysis of cognitive and imaging measures as defined by sex | In Progress | In Progress |
| Common close design in the API ADAD Colombia trail | Department of Neurosciences, University of San Diego School of Medicine & Banner Alzheimer's Institute | Discussion and proposal of common close trial design in as a method of increasing statistical power for the API ADAD Colombia trial | In Progress | In Progress |
| Structural equation modeling analysis | Banner Sun Health Research Institute | Structural equation modeling analysis, explore multifactorial correlational structure among latent variables & demographics, mutation carrier status & manifest variables | In Progress | In Progress |
| Clinical, cognitive and non-cognitive characteristics of screening for API ADAD Colombia trial | Groupa de Neurosciences, Universidad de Antioquia | Defining the characteristics of the screening cohort for API ADAD Colombia trial | In Progress | In Progress |
| Biomarkers in preclinical Alzheimer's Disease based on the resting state fMRI | Groupa de Neurosciences, Universidad de Antioquia | Observed characteristics of biomarkers in preclinical Alzheimer's Disease | In Progress | In Progress |
| Comparison of API ADAD Colombia and Dominantly Inherited Alzheimer's Network cohorts | Banner Alzheimer's Institute | Evaluation and comparison of the API and DIAN cohorts | In Progress | In Progress |
| White Matter Hyperintensitiy Volume and Florbetapir SUVR Load in PSEN1 E280 Carriers and Non-Carriers | Banner Alzheimer's Institute | Evaluation of White Matter Hyperintensitiy Volume and Florbetapir SUVR Load in PSEN1 E280 Carriers and Non-Carriers | In Progress | In Progress |
| Cholinergic basal forebrain volume and functional connectivity in asymptomatic PSEN1 E280A mutation carriers compared with non-mutation carriers from the Alzheimer’s Prevention Initiative Autosomal-Dominant Alzheimer’s Disease Trial | Department of Psychosomatic Medicine, University of Rostock & German Center for Neurodegenerative Diseases (DZNE) | 1. Cholinergic BF volume and functional connectivity in the baseline data of asymptomatic PSEN1 E280A mutation carriers compared with non-mutation carriers from the Alzheimer’s Prevention Initiative Autosomal-Dominant Alzheimer’s Disease Trial. 2. Association of basal forebrain volume and posterior basal forebrain functional connectivity with amyloid load in asymptomatic PSEN1 E280A mutation carriers based on amyloid sensitive PET data. | In Progress | In Progress |